Protea Biosciences Group Inc (PRGB) - Financial and Strategic SWOT Analysis Review



Protea Biosciences Group Inc (Protea) operates as a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applications. Its products include functionalized pipette tips and plates, gel protein separation and recovery, protein sample preparation, amplus HPLC columns and mass spectrometry standards. Proteas services include bioanalytical services and mass spec imaging services. The company’s bioanalytical services include biomarker discovery, advanced proteomics and protein, biotherapeutic characterization and peptide quantitation. It also provides label free imaging, translational, and drug and metabolite distribution. The company serves pharmaceutical, clinical, academic and industrial research. Protea is headquartered in Morgantown, West Virginia, the US.

This comprehensive SWOT profile of Protea Biosciences Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Protea Biosciences Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Protea Biosciences Group Inc - Key Information
Protea Biosciences Group Inc - Overview
Protea Biosciences Group Inc - Key Employees
Protea Biosciences Group Inc - Key Employee Biographies
Protea Biosciences Group Inc - Key Operational Heads
Protea Biosciences Group Inc - Major Products and Services
Protea Biosciences Group Inc - History
Protea Biosciences Group Inc - Company Statement
Protea Biosciences Group Inc - Locations And Subsidiaries
Protea Biosciences Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Protea Biosciences Group Inc - Business Description
Protea Biosciences Group Inc - Corporate Strategy
Protea Biosciences Group Inc - SWOT Analysis
SWOT Analysis - Overview
Protea Biosciences Group Inc - Strengths
Protea Biosciences Group Inc - Weaknesses
Protea Biosciences Group Inc - Opportunities
Protea Biosciences Group Inc - Threats
Protea Biosciences Group Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Protea Biosciences Group Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Protea Biosciences Group Inc, Key Information
Protea Biosciences Group Inc, Key Ratios
Protea Biosciences Group Inc, Share Data
Protea Biosciences Group Inc, Major Products and Services
Protea Biosciences Group Inc, History
Protea Biosciences Group Inc, Key Employees
Protea Biosciences Group Inc, Key Employee Biographies
Protea Biosciences Group Inc, Key Operational Heads
Protea Biosciences Group Inc, Other Locations
Protea Biosciences Group Inc, Subsidiaries
Protea Biosciences Group Inc, Key Competitors
Protea Biosciences Group Inc, SWOT Analysis
Protea Biosciences Group Inc, Ratios based on current share price
Protea Biosciences Group Inc, Annual Ratios
Protea Biosciences Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Protea Biosciences Group Inc, Performance Chart
Protea Biosciences Group Inc, Ratio Charts
 


20s Proteasome - Drugs in Development, 2021

20s Proteasome - Drugs in Development, 202120s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.

USD 3500 View Report

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1)

USD 3000 View Report

Protea Biosciences Group Inc (PRGB) - Medical Equipment - Deals and Alliances Profile.

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available